Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device

  • Pressure BioSciences develops and sells pressure-based instruments and consumables to the global life sciences, food and beverage, and other large research markets
  • Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”)
  • The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market, which is exponentially larger than the research products market where the Company currently transacts business
  • The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important and popular consumable to date
  • PBI has seen revenue from consumables steadily increase in recent years and double in just four years. The new patent provides greater security for its business model as well as potential for more explosive growth
  • Recent publications from highly regarded scientists in Australia, China, and the U.S., cite the important use of PCT and the PCT MP in critical areas of scientific research, including cancer and COVID-19 research

Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform solutions to the worldwide Life Sciences and other industries, has been awarded a pivotal U.S. patent for “Sample Preparation Devices and Methods” (http://ibn.fm/WL9XC).

With this new patent, the Company continues to expand its already significant intellectual property ownership, which now includes 25 issued patents.

Pressure BioSciences’ unique pressure cycling technology (“PCT”) systems are comprised of two major, interdependent components: the pressure cycling instrument and the consumable that contains and delivers the cycled pressure to the sample. The newly patented PCT MicroPestle (“MP”) is a critical addition to the Company’s impressive instruments and consumables product line.

The PCT MP is the Company’s most important and popular consumable to date, having a unique construction that seals and protects the sample while flexing to transfer immense pressures to the important samples being processed inside the MP tube. This, in turn, facilitates homogenization and precise physical and chemical preparation of biological samples, sometimes very small and hard-to-process specimens such as needle biopsies, small suspensions of cells, and laser micro-dissected tissue sections.

The PCT MicroPestle is designed with inert fluoropolymer material, which maintains stability for the sample as it experiences significant temperature fluctuations. The PCT MP also provides powerful resistance to aggressive chemicals. Extremely low surface binding characteristics enable the PCT MP to preserve and maximize the availability of each sample’s precious molecules, which often include important biomarkers for disease diagnosis or critical prognostic decisions regarding treatment selection and guidance.

Recent publications cite the use of PCT and the PCT MP in cancer and COVID-19 research, citing the use of the Company’s products in their studies to develop better methods for the detection, prevention, and cure of infectious diseases.

Prospective Financial Impact of the New Patent

With the PCT MP, Pressure BioSciences inches all that much closer to entering the clinical market, which has exponentially larger potential than the research market, where the Company currently transacts business. With just one proven clinical application of PCT and the PCT MP, Pressure BioSciences will have enormous potential for revenue.

PCT instruments tend to heavily impact revenue up front, while consumables continue to provide revenue potential throughout the life of the instrument. Pressure BioSciences has seen revenue from consumables steadily increase in recent years and double in just the past four years, from $150K in 2015 to $260K in 2017 and then $300K in 2019. The new patent provides even more security for this kind of growth and potential for more explosive growth.

Several high-profile labs in pharma, biotech, government, and academia routinely use the PCT MP. Publications about the capabilities of PCT MP are making their way into circulation and garnering attention. This is particularly true for the processing of minute cancer biopsy tissues and other small specimens where the options for a high-quality processing method are few and far between.

Worldwide Customer Demand

According to Ms. Roxana McCloskey, Pressure BioSciences’ Global Director of Sales and Marketing, the PCT MP is already used in prominent studies such as the one conducted by Professor Phil Robinson and his team at the Children’s Medical Research Institute in Australia (processing 70,000 tumor samples, looking for prognostic and diagnostic markers in cancer) and the one run by Dr. Tiannan Guo and his team at Westlake University in China (studying thyroid cancer and COVID-19).

The PCT MP is also a critical part of the innovative laser microdissection tumor processing workflow developed by Dr. Tom Conrads of the Inova Health System in the U.S. This important new tumor processing method promises the potential for significant improvements in the clinical management of most solid tumor cancers. Dr. Conrads’ novel workflow is the basis of Pressure BioSciences’ major co-marketing collaboration recently announced with Leica Microsystems (a Danaher company).

“It is clear why we see this award of the PCT MP patent as a critical milestone in securing our pivotal intellectual property around the PCT system, and another important driver toward accelerated adoption of PCT in biological sample preparation markets. We expect to take full advantage of this opportunity and further boost our sales,” Ms. McCloskey said.

Dr. Alexander Lazarev, Pressure BioSciences’ Chief Scientific Officer, added: “This long-anticipated patent is an exciting endorsement of our efforts to transform biological sample preparation. This powerful new dimension to our patent protected portfolio should help us to secure and accelerate the growth of our business.”

For more information, visit the company’s website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Eyes Opportunity Amid Climate Crisis

Energy Fuels (NYSE American: UUUU) (TSX: EFR) is positioned to capitalize on the government’s recent push for nuclear energy. On June 30, the U.S. House Select Committee released an action plan titled “Solving the Climate Crisis: The Congressional Action Plan for a Clean Energy Economy and a Healthy, Resilient, and Just America.” Among ambitious initiatives, the plan proposes establishment of a national clean-energy standard that encourages zero-emission carbon technologies — such as nuclear — to achieve net-zero emissions in the electricity sector by 2040. A recent article discussing the company’s opportunity amid sweeping reform reads, “As the country’s leading uranium and vanadium producer, Energy Fuels is well positioned to capitalize on the growing demand for clean energy. Energy Fuels has also recycled over 6 million pounds of uranium from its alternate feed recycling program. The carbon-free electricity produced from this recycled uranium would be the equivalent of a train full of coal that stretched from Los Angeles to New York — and back again — thereby avoiding 85 million tons of CO2 emissions. Among clean-energy options, nuclear is recognized as one of the most reliable, affordable and stable, contributing to 55% of all clean-energy production throughout the country in 2019 (http://ibn.fm/JUuM2). In terms of carbon emissions and air pollution reduction, Energy Fuels is one of the greenest companies operating in the U.S.”

To view the full article, visit http://ibn.fm/MOdcM

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant. Its corporate offices are near Denver, Colorado, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the United States today, has a licensed capacity of over 8 million pounds of U3O8 per year and has the ability to produce vanadium when market conditions warrant. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also currently on standby. In addition to the above production facilities, Energy Fuels has one of the largest NI 43-101 compliant uranium resource portfolios in the United States, including several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol UUUU; the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol EFR. For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Energy Fuels Inc. UUUU | Leave a comment

MissionIRNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Launches iActivate Upgrade

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced its launch of an upgrade of its ultimate advertising campaign management tool, iActivate. A comprehensive solution, iActivate consolidates a number of ad platforms into one single interface for efficient campaign monitoring and management. “iActivate provides straightforward and intelligent market insights that address the pain points faced by marketers of receiving insufficient and overly-general campaign data from existing ad platforms,” Frankie Ho, president of International Business at iClick, stated in the news release. “iActivate helps brands analyze and understand campaign performance in order to target audiences more accurately, empowering them to respond promptly to market changes. Following the upgrade of iAudience and iActivate, we will continue to leverage iClick’s over 930 million consumer profiles and advanced technology in machine learning and artificial intelligence to enhance and improve our product offerings to provide better solutions to our clients.”

To view the full press release, visit http://ibn.fm/yJ0Zq

About iClick Interactive Asia Group Limited

iClick Interactive Asia Group is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, iClick’s proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in ten locations worldwide, including Asia and Europe.

For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in iClick Interactive Asia Group Ltd. ICLK, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) Announces Appointment of 3D Printing Industry Veteran

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, today announced its appointment of Steve Immel to the position of Senior Director Business Development, North America. Steve, a veteran of the 3D printing industry, will be responsible for engaging with 3D printer OEMS, additive manufacturers, academic institutions and research organizations to propel Sigma Labs PrintRite3D(R) in-process quality assurance solutions into production applications. “We are extremely pleased to welcome someone of Steve Immel’s caliber,” Sigma Labs’ Vice President of Business Development, Ron Fisher, stated in the news release. “Steve brings to Sigma Labs a unique mix of in-depth experience in CAD/CAM/CAE software, 3D printer hardware and production manufacturing combined with passion for advancing the industry. He will be a great asset to our company and, most important, to our customers and partners.”

To view the full press release, visit http://ibn.fm/yX2mF

About Sigma Labs, Inc.

Sigma Labs is a leading provider of quality assurance software to the commercial 3D metal printing industry under the PrintRite3D(R) brand. Sigma specializes in the development and commercialization of real-time monitoring solutions known as PrintRite3D(R) for 3D metal advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process and informs the production manager of quality issues. Sigma Labs’ software product is a major catalyst for the acceleration and adoption of 3D metal printing. For more information, please visit www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB  

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Sigma Labs Inc. SGLB | Leave a comment

SRAX Inc.’s (NASDAQ: SRAX) Sequire Platform Proof Positive of Company’s Relevance in Today’s Changing Markets

  • Sequire now available as free mobile app, gives SRAX clients benefits of entire platform
  • With mobile app, companies can monitor behaviors, contributions of investors anytime and anywhere
  • Since its release, Sequire has surpassed 500,000 active investors and traders, sales have exceeded $2.5 million

In a world transformed by a worldwide epidemic, companies that offer flexible services and options that support new ways of doing business appear to be ideally positioned for success. With Sequire, SRAX Inc. (NASDAQ: SRAX) has honed in on precisely what today’s public businesses are looking for. The proprietary investor intelligence and communications platform provides an intuitive, virtual method for companies to monitor retail and institutional investors as well as activate media campaigns to engage existing investors while attracting new ones — and the newest additions to the platform illustrate how effective SRAX is at adapting to a world that is moving online.

Originally available as a computer app, Sequire is now also available as a mobile app and can be downloaded for free on the App Store and Google Play (http://ibn.fm/gwBNW), allowing SRAX clients to enjoy all the benefits of the entire platform regardless of where they are. With Sequire, businesses can unlock stock buyers’ behaviors and trends; manage and monitor return on investment from investor relations programs and corporate communications firms; and engage current and potential stock buyers at their trading desks, investor events or at home on both desktop or mobile.

“We are thrilled to launch the Sequire mobile app enabling our clients to now monitor their investors’ behaviors and their contributions anytime and anywhere,” said SRAX CEO and founder Christopher Miglino. “We’ll also be launching more exciting mobile features in the next few months, so stay tuned.”

Clear evidence of SRAX’s ability to recognize what today’s market demands is the success of the platform. Since its release, Sequire has surpassed 500,000 active investors and traders while sales have exceeded $2.5 million in Q2 2020 (http://ibn.fm/5RIyk), In addition, the addition of Sequire’s relatively new Virtual Roadshow, which allows companies to host one-on-one or one-to-many video and audio meetings (http://ibn.fm/jnQSx), shows how nimble and relevant the company can be.

With virtual communication deemed an essential component of today’s business operations, the Virtual Roadshow provides a safe, effective way for companies to present their stories to new shareholders, offer quarterly and annual updates to existing shareholders, and reach out to a wide range of individuals and entities.

“The ecosystem for investor events will be changed forever after the current environment,” said Miglino. “Investors and issuers will no longer need to meet in person. New technologies are providing the tools that issuers need to meet with current and prospective investors. The organizers of these events are the cornerstone of the industry and our system will allow for them to create their own events on the platform and profit from letting issuers invite investors from proprietary lists to the issuers roadshows. Video is the future of investor communication, and we are thrilled to add this feature to the platform.”

SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury, and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. In addition to BIGtoken, the company offers Sequire, a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX        

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in SRAX, Inc. SRAX | Leave a comment

Trxade Group, Inc. (NASDAQ: MEDS) to Present at LD Micro’s LD 500 Virtual Conference

  • The exclusively online LD 500 event is expected to gather more than 300 companies and 20,000 attendees in early September
  • Trxade reported record revenue in Q2 2020 and expects a strong second half of the year
  • If telemedicine services maintain popularity, market analysts project a seven-fold increase for the industry by 2025

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, will present at the virtual LD 500 in early September to an expected online audience of more than 20,000.The event is organized by LD Micro, an independent resource to the microcap world, which started off as a newsletter highlighting unique companies and has transformed into the pre-eminent event platform in the space.

The upcoming LD 500, taking place September 1st-4th, 2020, is the company’s most ambitious project yet, and the first event that can be accessed by anyone. It is expected to feature over 300 companies and more than 20,000 attendees, according to LD Micro President Chris Lahiji.

“For the first time in ten years, we were unable to host our mid-year conference, which caused us to dream up the LD 500,” stated Lahiji. “While the economy and financial world have been turned upside down, investor interest is as high as we have ever seen, and we will have something for everyone.”

This news comes on the heels of Trxade Group reporting record revenues for the second quarter of 2020 and projections for a strong second half of the year. According to a company announcement, revenues increased 244% to a record $6.6 million, compared to revenue of $1.9 million in the same quarter last year. Second quarter revenue was up 199% when compared to revenues of $2.2 million in the first quarter of 2020 (http://ibn.fm/wCopy).  

“As we move through the second half of 2020, we are better positioned than ever to execute upon our vision of continued growth of the platform, driven by new independent pharmacies, new suppliers and distributors,” Chairman and Chief Executive Officer Suren Ajjarapu said.

The revenue surge was primarily due to a significant increase in personal protective equipment (“PPE”) sales by the company’s Integra Pharma segment in response to the COVID-19 pandemic.

During the COVID-19 crisis, telehealth services have rapidly expanded. As a result, the company has been working to raise awareness of its supply chain trading platform that includes medical consultation and prescription drug solutions. As the spread of the novel coronavirus unexpectedly reached pandemic proportions and triggered the need for infection-fighting policies, Trxade Group has developed measures to help patients and providers continue to access resources through a virtual environment that is safe from contagion.

If telemedicine services maintain popularity with patients, and insurance providers continue to be responsive to reimbursing telehealth claims, market analysts at McKinsey & Company forecast a $250 billion telehealth market (http://ibn.fm/MZqNY) while Frost & Sullivan projects a seven-fold increase in telehealth by 2025 (http://ibn.fm/2x5DG).

Headquartered in Tampa, Florida, Trxade Group, Inc. is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. The company operates across all 50 states with the central mission of making healthcare services affordable and accessible.

Trxade operates via four synergistic platforms: (1) B2B trading platform with 11,725 registered pharmacies; (2) Integra Pharma Solutions, the company’s virtual wholesale division; (3) Bonum Health which offers affordable telehealth services; and (4) the DelivMeds app, a nationwide mail order delivery distribution network for independent pharmacies.

For more information, visit the company’s website at www.TrxadeGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Achieves Critical Milestone Through Award of Key Patent

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of a key U.S. patent entitled “Sample Preparation Devices and Methods.” According to the update, the new patent (U.S. 10,710,082) brings the company’s intellectual property (“IP”) estate up to a total of 25 issued patents. “We have many customers worldwide who routinely use our ‘PCT’ Micro-Pestle consumable in their research studies. These include Professor Phil Robinson and his team at the Children’s Medical Research Institute in Australia (processing 70,000 tumor samples, looking for prognostic and diagnostic markers in cancer) and Dr. Tiannan Guo and his team at Westlake University in China (studying thyroid cancer and COVID-19),” Pressure BioSciences’ Global Director of Sales and Marketing, Roxana McCloskey, said in the news release. “The PCT MP is also a critical part of the innovative laser microdissection tumor processing workflow developed by Dr. Tom Conrads of the Inova Health System in the U.S. This important new tumor processing method promises significant improvements in the clinical management of most solid tumor cancers. His novel workflow is the basis of our major co-marketing collaboration recently announced with Leica Microsystems (a Danaher Company). It is clear why we see this award of the PCT MP patent as a critical milestone in securing our pivotal intellectual property around the PCT system, and another important driver toward accelerated adoption of PCT in biological sample preparation markets. We expect to take full advantage of this opportunity and further boost our sales.”

To view the full press release, visit http://ibn.fm/l9aOL

About Pressure BioSciences, Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Its products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control biomolecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Expands Channel Partner Distribution to Include Leading ‘DSD’ Provider – Mahaska

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused waters and CBD-infused products, today announced that its entire line of beverage offerings, including flavored waters, will be carried by Mahaska, a leading direct-store-deliver (“DSD”) provider in some of the major markets in the Midwest. “We are excited to announce the addition of Mahaska to our growing list of channel partners. As a best in class provider, the partnership opens an important regional market for us in our pursuit to be a national lifestyle brand across all major retail channels,” Richard Wright, president and CEO of The Alkaline Water Company, stated in the news release. “In addition to their strong presence in the supermarket and convenience store channel, Mahaska also serves an extensive network of vending providers and micro-markets, which could eventually open an exciting new growth market for us. This ties nicely with our major growth initiative of penetrating the hospitality space during our current fiscal year. With our superior taste profile and increasing consumer demand for healthier and eco-friendly options, we believe our brands will be a hit with their customers.”

To view the full press release, visit http://ibn.fm/KWDHd

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88(R) delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label “Clean Beverage.” Quickly being recognized as a growing lifestyle brand, Alkaline88(R) launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused(TM) flavored water is available in seven unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested full-spectrum hemp salves, balms, lotions, essential oils, and bath salts, along with broad-spectrum hemp beverage shots, powder packs, oil tinctures, capsules, and gummies. To purchase A88CBD(TM) products online, visit www.A88CBD.com. To learn more about The Alkaline Water Company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER  

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, The Alkaline Water Company Inc. WTER | Leave a comment

Electric Sports Car Manufacturing Coming to Washington State Via Proposed Merger Between Net Element Inc. (NASDAQ: NETE) and Mullen Technologies

  • Mullen Technologies plans to open electric vehicle manufacturing facility in West Plains via proposed merger with NETE
  • Reverse merger will give Mullen stakeholders majority in newly formed company while accelerating process of taking Mullen public
  • Proposed 1.3 million square foot manufacturing facility is expected to create up to 4000 jobs by 2026

Mullen Technologies (“Mullen”) plans to bring electric vehicle (“EV”) manufacturing to West Plains, Washington through a proposed merger with Net Element (NASDAQ: NETE), a global technology group based in Miami that operates electronic payment services.

While still in its planning stages, the new EV manufacturing facility will comprise 1.3 million square feet of assembly and manufacturing space. A total of nearly 4000 jobs are expected to be created that include 55 at startup, 863 by 2026, and an additional 3,000 from the research and development of lithium-ion batteries through Mullen’s subsidiary company, Mullen Energy.

“We believe the timing of this merger is ideal for Mullen Technologies,” Mullen CEO David Michery said in recent statements (http://ibn.fm/b0ZoJ). “It comes on the preparation of our launch of the Dragonfly K50, which will be available in (the second quarter) of 2021 through our retail network in California and Arizona, and the development of a new EV model, the MX-05 Sport Utility Vehicle.”

Electric vehicle sales have grown substantially in recent years due to the falling prices of EV batteries, changes in fuel regulations and electric vehicle mandates in countries like China, which is expected to account for almost half (48%) of all passenger car sales in 2025, according to research by BloombergNEF (http://ibn.fm/LDvxf). Besides taking over most of the global passenger market by 2040, the report also predicts that electric vehicles will dominate municipal bus sales by 81% while taking 56% of light commercial vehicle sales and 31% of the medium commercial market.

Plans for the West Plains manufacturing plant are expected to accelerate following the merger, anticipated to occur in the third quarter of 2020. Pending stockholder and NASDAQ approval, the reverse merger between the companies will allow the stakeholders of Mullen Technologies, a privately held company, to acquire a majority of the stock in the newly formed company while accelerating the process of taking Mullen public and expanding its manufacturing operations.

NETE helps businesses of all sizes deliver innovative, virtually seamless payment systems with services that also include marketing solutions and business analytics.  Ranked by Deloitte in 2017 and 2018 as one of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies, NETE credits its progression to organic growth in its North America transactions segment.

For more information, visit the company’s website at www.NetElement.com.

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Net Element Inc. NETE | Leave a comment

Energy Fuels (NYSE American: UUUU) (TSX: EFR) Focused on Eliminating Debt, Growing Uranium Inventory

  • UUUU has eliminated half of the company’s debt, plans to be debt free by end of 2020
  • Company will have estimated $30 million of uranium & vanadium inventory — more if market prices rise — by end of 2020
  • Energy Fuels working toward producing rare earth elements in the U.S.

The largest uranium mining company in the United States, Energy Fuels (NYSE American: UUUU) (TSX: EFR) has eliminated one-half of its debt, plans to be debt free by the end of the year, and anticipates having $30 million of inventory value by the close of 2020 (http://ibn.fm/YpNEV). The company holds three of America’s key uranium production centers, including the White Mesa Mill, the only conventional uranium mill currently operating in the United States today.

“The strength of Energy Fuels’ balance sheet is unsurpassed in the global mid- and junior-uranium mining sectors today, including decreasing debt loads and increasing values on our product inventories,” said Energy Fuels president and CEO Mark S. Chalmers.

Uranium mining peaked in the 1980s with more than 250 operating mines, making the United States the world’s largest producer of energy fuels at that time. The situation has changed significantly since then. The U.S. now ranks 15th in the world and produces a mere 1% of the world’s uranium (http://ibn.fm/sEY6i) and less than 1% of U.S. requirements (http://ibn.fm/S120N).

Nuclear energy is clean energy, generating 20% of all electricity and more than 55% of the carbon-free, emission-free electricity in the country. Its continued use is vital in combating global climate change and air pollution, while also remaining affordable.

Energy Fuels is the top U.S. producer of uranium, supplying over one-third of the nation’s needs for the past 15 years. However, the country continues to import the majority of its uranium from foreign countries. Energy Fuels is working to change this by leading efforts in the 2018–2019 Uranium Section 232 (http://ibn.fm/OSTJQ), the Nuclear Fuel Working Group (http://ibn.fm/dWqGS), and the proposed creation of the new U.S. strategic uranium reserve (http://ibn.fm/1iMCl).

“No other comparable uranium miner to my knowledge has Energy Fuels’ inventory levels, and many are incurring significant debt to advance their development and exploration projects,” Chalmers stated. Decreasing debt has been a focus of Energy Fuels over the last several years. Being debt free by the end of 2020 protects the shareholders if the market does not meet expectations. 

Energy Fuels anticipates 640,000 to 690,000 pounds of uranium inventory by the end of 2020; at the current value of uranium that is about a$22,000,000 value. Also, Chalmers shared that the company has 1,675,000 pounds of high-purity finished vanadium product, worth around $8.9 million at today’s prices. “I can think of no other comparable uranium miner anywhere in the world that has the potential to have over $30 million of inventory value at the end of 2020 — and possibly much more if uranium and/or vanadium prices improve,” he stated.

The company is looking into entering the rare earth elements (“REE”) space as well, which will incorporate the recycling of REE-bearing materials (http://ibn.fm/zjTe0). There is a lot of interest in rare earths at the current time, and Energy Fuels management believe the company is more advanced than other companies in the U.S. with respect to producing a salable rare earth concentrate (http://ibn.fm/xADbd).  

Uranium recycling, vanadium production and the alternate-feed material recycling program have also created diverse cash-flow-generating opportunities for Energy Fuels that has played into the company’s ability to reduce debt while remaining environmentally responsible. The company’s alternate-feed material recycling program takes waste from non-mine sources and industrial activities and produces uranium, a clean-energy resource.

For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Energy Fuels Inc. UUUU | Leave a comment